← Back to Search
A Double‐blind, Placebo‐controlled Trial
R. Pinals, S. Kaplan, J. Lawson, B. Hepburn
Published 1986 · Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Sulfasalazine (SSZ), 3 gm daily, was compared with placebo for treatment of rheumatoid arthritis, in a 15-week randomized, parallel, double-blind trial. Joint tenderness and swelling, morning stiffness, grip strength, and pain score all showed significantly more improvement with SSZ than with placebo. Adverse effects, particularly gastrointestinal reactions, led to withdrawal from the study of 28% of the patients who had been receiving SSZ, but these effects were all readily reversible and not life-threatening. These results confirm previous findings that suppression of rheumatoid synovitis may be induced by SSZ, within 2 months after full maintenance doses are reached.
This paper references
Salazopyrin in the Treatment of Rheumatoid Arthritis
R. Sinclair (1949)
A Seven‐Day variability study of 499 patients with peripheral rheumatoid arthritis
D. Mainland (1965)
Intestinal Clostridium perfringens in rheumatoid arthritis and other collagen diseases.
B. Olhagen (1968)
Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease
B. West (1974)
Clinical Pharmacokinetics of Sulphasalazine
K. Das (1976)
AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE
A. Khan (1977)
Comparative analysis of systemic immunological parameters in ulcerative colitis and idiopathic proctitis: effects of sulfasalazine in vivo and in vitro.
A. Rubinstein (1978)
Effects of sulfasalazine on selected lymphocyte subpopulationsin vivo andin vitro
W. Thayer (1979)
Sulphasalazine in rheumatoid arthritis.
B. McConkey (1980)
Effect of metronidazole and sulfasalazine on the normal human faecal flora.
A. Krook (1981)
Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.
W. Stenson (1982)
Multiple haematologic abnormalities associated with sulfasalazine.
K. Wheelan (1982)
Preliminary criteria for clinical remission in rheumatoid arthritis.
R. Pinals (1982)
A biochemical assessment of sulphasalazine in rheumatoid arthritis.
H. Bird (1982)
Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease.
O. Nielsen (1982)
Folate status in patients receiving maintenance doses of sulfasalazine.
G. Longstreth (1983)
Inhibition of platelet thromboxane synthetase by sulfasalazine.
W. Stenson (1983)
Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
T. Pullar (1983)
Sulfasalazine. Adverse effects and desensitization.
S. Taffet (1983)
Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
V. Neumann (1983)
Pulmonary infiltrates and eosinophilia associated with sulfasalazine.
K. Wang (1984)
Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development.
M. Peppercorn (1984)
Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.
K. Grindulis (1984)
Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity.
L. Martin (1985)
Does sulphasalazine cause folate deficiency in rheumatoid arthritis?
K. Grindulis (1985)
Which component of sulphasalazine is active in rheumatoid arthritis?
T. Pullar (1985)
Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis.
T. Pullar (1985)
This paper is referenced by
Hypertension-induced cognitive impairment: from pathophysiology to public health
Z. Ungvari (2021)
Protective Role of Trans-chalcone against the Progression from Simple Steatosis to Non-alcoholic Steatohepatitis: Regulation of miR-122, 21, 34a, and 451
Elham Karimi-Sales (2021)
Exploring the therapeutic potential of omega-3 fatty acids in depression
Priyanshi Sikka (2021)
Dexamethasone increased the survival rate in Plasmodium berghei-infected mice
Danilo R. Moreira (2021)
Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment
M. Leutner (2021)
Hydrophilic or Lipophilic Statins?
E. Climent (2021)
The use of nasal allergen vs allergen exposure chambers to evaluate allergen immunotherapy
L. Hossenbaccus (2021)
The efficacy of botulinum toxin A treatment for tension-type or cervicogenic headache: a systematic review and meta-analysis of randomized, placebo-controlled trials
Sissel Breivold Roland (2021)
The effect of probiotics on respiratory tract infection with special emphasis on COVID-19: Systemic review 2010–20
Atieh Darbandi (2021)
Associations of hypertension burden on subsequent dementia: a population-based cohort study
Hyunjean Jung (2021)
Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?
Gabriel Tayguara Silveira Guerreiro (2021)
The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis
J. Segal (2021)
Statins in Depression: An Evidence-Based Overview of Mechanisms and Clinical Studies
Riccardo De Giorgi (2021)
Cysteine dependence in Lactobacillus iners constitutes a novel therapeutic target to modify the vaginal microbiota
S. M. Bloom (2021)
Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
V. Venditto (2021)
Elevated Plasma Melatonin Levels Are Correlated With the Non-motor Symptoms in Parkinson’s Disease: A Cross-Sectional Study
Linyi Li (2020)
Sulodexide for the Symptoms and Signs of Chronic Venous Disease: A Systematic Review and Meta-analysis
A. Bignamini (2020)
Gut Microbiota Profiles and Microbial-Based Therapies in Post-operative Crohn's Disease: A Systematic Review
Xiaojun Zhuang (2020)
Paradoxical Effects of a Cytokine and an Anticonvulsant Strengthen the Epigenetic/Enzymatic Avenue for Autism Research
D. Béroule (2020)
Pain Management in Childhood Leukemia: Diagnosis and Available Analgesic Treatments
F. Coluzzi (2020)
The efficacy of probiotics in management of recurrent aphthous stomatitis: a systematic review and meta-analysis
Bin Cheng (2020)
Eucalyptus oil reduces allergic reactions and suppresses mast cell degranulation by downregulating IgE-FcεRI signalling
Tomoya Nakamura (2020)
Title: Binding of SARS-CoV-2 spike protein to ACE2 is disabled by thiol-based drugs; evidence from in vitro SARS-CoV-2 infection studies. One Sentence Summary: Thiol-based drugs decrease binding of SARS-CoV-2 spike protein to its receptor and inhibit SARS-CoV-2 cell entry
Kritika Khanna (2020)
Vascular protection and regenerative effects of intranasal DL-3-N-butylphthalide treatment after ischaemic stroke in mice
Mengyao Qu (2020)
Plasma BDNF is a more reliable biomarker than erythrocyte omega-3 index for the omega-3 fatty acid enrichment of brain
D. Sugasini (2020)
Efficacy of scopolamine transdermal patch in children with sialorrhea in a pediatric tertiary care hospital
Majed Al Jeraisy (2020)
Contemporary stable isotope tracer approaches: Insights into skeletal muscle metabolism in health and disease
M. Brook (2020)
Brain interstitial fluid drainage and extracellular space affected by inhalational isoflurane: in comparison with intravenous sedative dexmedetomidine and pentobarbital sodium
Guomei Zhao (2020)
Lactic Acid Bacteria: Food Safety and Human Health Applications
Raphael Ayivi (2020)
Are non-abstinent reductions in World Health Organization drinking risk level a valid treatment target for alcohol use disorders in adolescents with ADHD?
Henry M. Mitchell (2020)
Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment
Katharine Boaden (2020)
Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide
A. Soriano (2020)See more